PRMT1 and cancer: PRMT1 is also involved in the progression of the liver [69], osteosarcoma [70], glioma [71], thyroid, pancreatic [72], leukemia [73–76], ovarian [77,78], and gastric [79] cancers by methylating various substrate proteins as summarized in Table 2.